A Study of Injectable BLB101 and Blincyto in Adult Participants With R/R CD19+ B-ALL

Blincyto (blinatumomab) - Amgen

BLB-101 - BayLink Biosciences

recombinant parainfluenza virus 5 vaccine (BLB101) - CyanVac LLC, The University of Iowa

http://clinicaltrials.gov/ct2/show/NCT07723911

Jul 24, 2026